Enter a keyword or phrase to search all pages in this section:


Advanced search

Archive:

Looking for a previously published document in this section?

Press Release: Tixylix cough and cold medicines recalled by Novartis

Press release

Date: 13 December 2013
Time: 10:30
Contact: Press Office 020 3080 7651
or press.office@mhra.gsi.gov.uk
Out-of-hours 07770 446 189

The Medicines and Healthcare products Regulatory Agency (MHRA) has today issued a Drug Alert recalling certain batches of Novartis Consumer Health UK Ltd’s Tixylix cough and cold medicines from consumers.

This is because Novartis Consumer Health Ltd have been made aware of a possible fault in the manufacturing process of the tamper seal that might result in small pieces of plastic being found in the liquid medicines.

There is currently no evidence of people having problems as a result of this manufacturing fault but they are being asked to return the following medicines as a precautionary measure.

Specific batches of the Tixylix medicines below are being recalled by Novartis:

Tixylix Toddler Syrup 100ml
(Glycerol)

PL 00030/0150

Tixylix Toddler Syrup 150ml
(Glycerol)

PL 00030/0150

Tixylix Baby Syrup 100ml
(Glycerol)

PL 00030/0150

Tixylix Blackcurrant Flavour Syrup 100ml
(Glycerol)
PL 00030/0150
Tixylix Chesty Cough 100ml
(Guaifenesin)
PL 00030/0082


Adam Burgess, the MHRA’s Head of Defective Medicines Reporting Centre (DMRC), said:

“This is a precautionary recall and there is currently no evidence that people have had any problems with these medicines.

“If people have bought Tixylix we ask that they check the batch number on the bottle label next to the expiry date to see if it is one of the batches being recalled. If anyone has an affected batch they should return it to the place of purchase for a refund. If people do have any questions they can contact Novartis on 0800 854 100 or visit tixylix.co.uk.”

Notes to Editor

1. People can identify the affected products from the batch numbers that are listed below:

TIXYLIX  BABY SYRUP 100ML

10RR

100 ml

 

11RR

100 ml

 

1SS

100 ml

 

2SS

100 ml

 

2TT

100 ml

 

8SS2

100 ml

 

8VV

100 ml

TIXYLIX BLACKCURRANT FLAVOUR SYRUP  100ML

1VV

100 ml

 

3VV

100 ml

 

3VV2

100 ml

TIXYLIX CHESTY COUGH  100ML

1RR

100 ml

 

1TT

100 ml

 

2RR

100 ml

TIXYLIX TODDLER SYRUP 100ML

10SS2

100 ml

 

11SS

100 ml

 

12RR

100 ml

 

13RR

100 ml

 

13RR2

100 ml

 

1RR

100 ml

 

1TT

100 ml

 

2RR

100 ml

 

2VV

100 ml

 

3RR

100 ml

 

4RR

100 ml

 

4VV

100 ml

 

5RR

100 ml

 

5VV

100 ml

 

6RR

100 ml

 

6VV

100 ml

 

7RR

100 ml

 

7RR2

100 ml

 

7VV

100 ml

 

8RR

100 ml

 

9RR

100 ml

 

9SS

100 ml

TIXYLIX TODDLER SYRUP 150ML

12SS

150 ml

 

 

 

 

14RR

150 ml


2. Please see link to the company led recall

3. The MHRA is responsible for regulating all medicines and medical devices in the UK by ensuring they work and are acceptably safe. Underpinning all our work lies robust and fact-based judgements to ensure that the benefits justify any risks. The MHRA is a centre of the Medicines and Healthcare Products Regulatory Agency which also includes the National Institute for Biological Standards and Control (NIBSC) and the Clinical Practice Research Datalink (CPRDA is an executive agency of the Department of Health.

Page last modified: 13 December 2013